HERINGS develops an AI Biostatistics Solution that facilitates efficient and low-risk clinical trials and an AI Clinical Research Platform that supports everything from product strategy and clinical trial design to data management and statistical analysis.

Moovcare® is a medical application that needs to be prescribed by your oncologist and helps you stay connected to your medical team. If your physician determines that you are eligible to be included into Moovcare® platform, you will start receiving a digital questionnaire once a week, which you can answer via your smartphone, laptop or tablet.

You will be required to self report your symptoms, Moovcare® algorithm will analyse your answers and if it detects an anomaly or complication, an immediate notification will be sent to your treating physician. Moovcare is a digital therapeutic that uses a simple questionnaire to detect relapse or complications during follow-up of lung cancer patients. It enables monitoring patient symptoms on a weekly basis and alerting medical teams to the first signs of an anomaly. It was founded in 2014 and is based in Jerusalem, Israel.

Moovcare is a digital therapeutic that uses a simple questionnaire to detect relapse or complications during follow-up of lung cancer patients. It enables monitoring patient symptoms on a weekly basis and alerting medical teams to the first signs of an anomaly. It was founded in 2014 and is based in Jerusalem, Israel.

We identify the exact pain points in current medical care system, prioritize them according to their significance and clinical implication, develop evidence based, science embedded solution algorithms, and implement them through our digital service platform.

Moovcare® was proven in a clinical study to significantly improve lung cancer patients’ well being, as well as the communication with the medical team.